Yizhou Jiang

10.9k citations
93 papers · 1.9k indexed · 2 hit papers · h-index 22
Topics
CAR-T cell therapy research (30 papers)Biosimilars and Bioanalytical Methods (12 papers)Gastric Cancer Management and Outcomes (11 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaBlood
Partner nations
United StatesChinaFrance

In The Last Decade

Yizhou Jiang

84 papers receiving 1.8k citations

Hit Papers

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19...201720262020202320172025100200300400

Peers

Yizhou Jiang
Comparison fields: 5 of 111
  • Oncology 1.0k
  • Molecular Biology 465
  • Pulmonary and Respiratory Medicine 392
  • Surgery 262
  • Pathology and Forensic Medicine 239
Replace Sang Won Shin with:
Sang Won Shin South Korea
Hein B.A.C. Stockmann Netherlands
Steven C. Cunningham United States
Jun‐Eul Hwang South Korea
Harold S. Ballard United States
Wei Phin Tan United States
Hee Kyung Ahn South Korea
P Selby United Kingdom
P. Dirschedl Germany
Rajen Mody United States
Yizhou Jiang relative to Sang Won Shin South Korea Sang Won Shin's profile →
Citations per field
00.5×
Sang Won Shin · 1×
Citations per year

Countries citing papers authored by Yizhou Jiang

Since Specialization
Citations

This map shows the geographic impact of Yizhou Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yizhou Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yizhou Jiang more than expected).

Fields of papers citing papers by Yizhou Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yizhou Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yizhou Jiang. The network helps show where Yizhou Jiang may publish in the future.

Co-authorship network of co-authors of Yizhou Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Yizhou Jiang. A scholar is included among the top collaborators of Yizhou Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yizhou Jiang. Yizhou Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 1
5 1
6 5
7 4
8 17
9 8
10 39
11 89
12 9
13 7
14 23
15 4
16
A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED PHASE 2 STUDY OF GANITUMAB OR RILOTUMUMAB WITH PLATINUM-BASED CHEMOTHERAPY AS FIRST-LINE TREATMENT FOR EXTENSIVE-STAGE SMALL-CELL LUNG CANCER (SCLC)
4
17 64
18 42
19 23
20 52

About Yizhou Jiang

Yizhou Jiang is a scholar working on Hepatology, Oncology and Clinical Biochemistry, having authored 93 papers that have together received 1.9k indexed citations. Recurring topics across this work include CAR-T cell therapy research (30 papers), Biosimilars and Bioanalytical Methods (12 papers) and Gastric Cancer Management and Outcomes (11 papers). The work is most often cited by research in Oncology (1.0k citations), Hepatology (233 citations) and Gastroenterology (73 citations). Yizhou Jiang has collaborated with scholars based in United States, China and France. Frequent co-authors include John M. Rossi, Adrian Bot, Wen‐Jia Zuo, William Y. Go, Frederick L. Locke, Jeff Aycock, Sattva S. Neelapu, Tanya Siddiqi, Meg Elias and Nancy L. Bartlett. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026